ICON to Acquire ClinicalRM

ICON plc has agreed to acquire Clinical Research Management Inc. (ClinicalRM), expanding its access to government sponsored research and its capabilities in vaccines and infectious disease.
 
ClinicalRM provides full service and functional research services to range of U.S. government agencies with expertise across basic and applied research, infectious diseases, vaccines development and testing and bio-threats. They have also worked with government and commercial customers to respond to global viral epidemics.
 
ICON’s chief executive officer, Ciaran Murray said, “The market for government sponsored research is significant with over fifteen hundred active clinical studies being funded by the National Institutes of Health or other federal agencies. ClinicalRM has strong relationships and a deep understanding of what is required to partner successfully with government sponsors. ClinicalRM’s experience in responding to the challenges of global viruses will further enhance ICON’s capabilities in the areas of vaccines and infectious disease.”
 
Victoria Tifft, chief executive officer of ClinicalRM added, “We are delighted to be joining ICON. By combining ClinicalRM’s expertise in government sponsored research with ICON’s breadth of services and global footprint we will be able to bring additional services and thought leadership to our customers. We are also excited about the potential the combination has to further innovate drug development in the area of Vaccines and Infectious diseases.”